130 related articles for article (PubMed ID: 31834935)
1. Retinoic acid synergizes with the unfolded protein response and oxidative stress to induce cell death in FLT3-ITD+ AML.
Masciarelli S; Capuano E; Ottone T; Divona M; Lavorgna S; Liccardo F; Śniegocka M; Travaglini S; Noguera NI; Picardi A; Petrozza V; Fatica A; Tamagnone L; Voso MT; Lo Coco F; Fazi F
Blood Adv; 2019 Dec; 3(24):4155-4160. PubMed ID: 31834935
[TBL] [Abstract][Full Text] [Related]
2. All-trans retinoic acid synergizes with FLT3 inhibition to eliminate FLT3/ITD+ leukemia stem cells in vitro and in vivo.
Ma HS; Greenblatt SM; Shirley CM; Duffield AS; Bruner JK; Li L; Nguyen B; Jung E; Aplan PD; Ghiaur G; Jones RJ; Small D
Blood; 2016 Jun; 127(23):2867-78. PubMed ID: 27103744
[TBL] [Abstract][Full Text] [Related]
3. Subcellular localization of the FLT3-ITD oncogene plays a significant role in the production of NOX- and p22
Moloney JN; Stanicka J; Cotter TG
Leuk Res; 2017 Jan; 52():34-42. PubMed ID: 27870947
[TBL] [Abstract][Full Text] [Related]
4. Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia Cells.
Wang R; Li Y; Gong P; Gabrilove J; Waxman S; Jing Y
Mol Cancer Ther; 2018 Sep; 17(9):1871-1880. PubMed ID: 29959200
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid and proteotoxic stress induce AML cell death overcoming stromal cell protection.
Liccardo F; Śniegocka M; Tito C; Iaiza A; Ottone T; Divona M; Travaglini S; Mattei M; Cicconi R; Miglietta S; Familiari G; Nottola SA; Petrozza V; Tamagnone L; Voso MT; Masciarelli S; Fazi F
J Exp Clin Cancer Res; 2023 Aug; 42(1):223. PubMed ID: 37653435
[TBL] [Abstract][Full Text] [Related]
6. CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia.
Bertoli S; Boutzen H; David L; Larrue C; Vergez F; Fernandez-Vidal A; Yuan L; Hospital MA; Tamburini J; Demur C; Delabesse E; Saland E; Sarry JE; Galcera MO; Mansat-De Mas V; Didier C; Dozier C; Récher C; Manenti S
Oncotarget; 2015 Nov; 6(35):38061-78. PubMed ID: 26515730
[TBL] [Abstract][Full Text] [Related]
7. Targeting on glycosylation of mutant FLT3 in acute myeloid leukemia.
Hu X; Chen F
Hematology; 2019 Dec; 24(1):651-660. PubMed ID: 31533545
[No Abstract] [Full Text] [Related]
8. Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3/ITD mutation.
Rausei-Mills V; Chang KL; Gaal KK; Weiss LM; Huang Q
Am J Clin Pathol; 2008 Apr; 129(4):624-9. PubMed ID: 18343790
[TBL] [Abstract][Full Text] [Related]
9. Synergistic killing of FLT3ITD-positive AML cells by combined inhibition of tyrosine-kinase activity and N-glycosylation.
Tsitsipatis D; Jayavelu AK; Müller JP; Bauer R; Schmidt-Arras D; Mahboobi S; Schnöder TM; Heidel F; Böhmer FD
Oncotarget; 2017 Apr; 8(16):26613-26624. PubMed ID: 28460451
[TBL] [Abstract][Full Text] [Related]
10. Phosphoproteome analyses reveal specific implications of Hcls1, p21-activated kinase 1 and Ezrin in proliferation of a myeloid progenitor cell line downstream of wild-type and ITD mutant Fms-like tyrosine kinase 3 receptors.
Habif G; Grasset MF; Kieffer-Jaquinod S; Kuhn L; Mouchiroud G; Gobert-Gosse S
J Proteomics; 2013 Jan; 78():231-44. PubMed ID: 23017497
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia.
Jebanesan DZP; Illangeswaran RSS; Rajamani BM; Vidhyadharan RT; Das S; Bijukumar NK; Balakrishnan B; Mathews V; Velayudhan SR; Balasubramanian P
Ann Hematol; 2024 Jun; 103(6):1919-1929. PubMed ID: 38630133
[TBL] [Abstract][Full Text] [Related]
12. The Potential Transcriptomic and Metabolomic Mechanisms of ATO and ATRA in Treatment of FLT3-ITD Acute Myeloid Leukemia.
Peng CJ; Fan Z; Luo JS; Wang LN; Li Y; Liang C; Zhang XL; Luo XQ; Huang LB; Tang YL
Technol Cancer Res Treat; 2024; 23():15330338231223080. PubMed ID: 38179723
[TBL] [Abstract][Full Text] [Related]
13. Targeting RIPK1 in AML cells carrying FLT3-ITD.
Hillert LK; Bettermann-Bethge K; Nimmagadda SC; Fischer T; Naumann M; Lavrik IN
Int J Cancer; 2019 Sep; 145(6):1558-1569. PubMed ID: 30828789
[TBL] [Abstract][Full Text] [Related]
14. Internal tandem duplication mutations in the tyrosine kinase domain of FLT3 display a higher oncogenic potential than the activation loop D835Y mutation.
Marhäll A; Heidel F; Fischer T; Rönnstrand L
Ann Hematol; 2018 May; 97(5):773-780. PubMed ID: 29372308
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic FLT3-ITD supports autophagy via ATF4 in acute myeloid leukemia.
Heydt Q; Larrue C; Saland E; Bertoli S; Sarry JE; Besson A; Manenti S; Joffre C; Mansat-De Mas V
Oncogene; 2018 Feb; 37(6):787-797. PubMed ID: 29059168
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide and all-trans retinoic acid suppress the expression of FLT3-ITD.
Liang C; Peng CJ; Wang LN; Li Y; Zheng LM; Fan Z; Huang DP; Tang WY; Zhang XL; Huang LB; Tang YL; Luo XQ
Leuk Lymphoma; 2020 Nov; 61(11):2692-2699. PubMed ID: 32536235
[TBL] [Abstract][Full Text] [Related]
17. Concurrent Inhibition of Pim and FLT3 Kinases Enhances Apoptosis of FLT3-ITD Acute Myeloid Leukemia Cells through Increased Mcl-1 Proteasomal Degradation.
Kapoor S; Natarajan K; Baldwin PR; Doshi KA; Lapidus RG; Mathias TJ; Scarpa M; Trotta R; Davila E; Kraus M; Huszar D; Tron AE; Perrotti D; Baer MR
Clin Cancer Res; 2018 Jan; 24(1):234-247. PubMed ID: 29074603
[No Abstract] [Full Text] [Related]
18. [Correlation of Fms-like tyrosine kinase 3 (FLT3) gene expression to FLT3/internal tandem duplication mutation in peripheral blood of acute myeloid leukemia.].
Xu B; Shi PC; Song XY; Tang JH; Zhou SY
Ai Zheng; 2009 Jun; 28(6):632-6. PubMed ID: 19635202
[TBL] [Abstract][Full Text] [Related]
19. Association of the EGF-TM7 receptor CD97 expression with FLT3-ITD in acute myeloid leukemia.
Wobus M; Bornhäuser M; Jacobi A; Kräter M; Otto O; Ortlepp C; Guck J; Ehninger G; Thiede C; Oelschlägel U
Oncotarget; 2015 Nov; 6(36):38804-15. PubMed ID: 26462154
[TBL] [Abstract][Full Text] [Related]
20. FLT3-ITD cooperates with Rac1 to modulate the sensitivity of leukemic cells to chemotherapeutic agents via regulation of DNA repair pathways.
Wu M; Li L; Hamaker M; Small D; Duffield AS
Haematologica; 2019 Dec; 104(12):2418-2428. PubMed ID: 30975911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
